Granted Patent
Utility
US 6,506,901 · App. 09/903,738
Substituted 2-(S)-hydroxy-3-(piperidin-4-yl-methylamino)-propyl ethers and substituted 2-aryl-2-(R)-hydroxy-1-(piperidin-4-yl-methyl)-ethylamine &bgr;-3 adrenergic receptor agonists
Inventors:
Robert J. Steffan, Mark Anthony Ashwell, Jeffrey Claude Pelletier, William Ronald Solvibile, Edward Matelan
Patented Case
View Patent ↗
Granted: Jan 14, 2003
Filed: Jul 12, 2001
Inventors
Robert J. Steffan
Mark Anthony Ashwell
Jeffrey Claude Pelletier
William Ronald Solvibile
Edward Matelan
Assignee (at issue)
Wyeth, LLC
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.